Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in <i>Drosophila</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36947517.
- Also identified by DOI 10.1073/pnas.2213857120 and PMC identifier 10068811.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Poly(ADP-ribose) polymerase-1 (PARP1) has been reported to play an important role in longevity. Here, we showed that the knockdown of the PARP1 extended the lifespan of <i>Drosophila</i>, with particular emphasis on the skeletal muscle. The muscle-specific mutant <i>Drosophila</i> exhibited resistance to starvation and oxidative stress, as well as an increased ability to climb, with enhanced mitochondrial biogenesis and activity at an older age. Mechanistically, the inhibition of PARP1 increases the activity of AMP-activated protein kinase alpha (AMPKα) and mitochondrial turnover. PARP1 could interact with AMPKα and then regulate it via poly(ADP ribosyl)ation (PARylation) at residues E155 and E195. Double knockdown of PARP1 and AMPKα, specifically in muscle, could counteract the effects of PARP1 inhibition in <i>Drosophila</i>. Finally, we showed that increasing lifespan via maintaining mitochondrial network homeostasis required intact PTEN induced kinase 1 (PINK1). Taken together, these data indicate that the interplay between PARP1 and AMPKα can manipulate mitochondrial turnover, and be targeted to promote longevity.
Medical subject headings
- Drosophila Proteins
- Poly (ADP-Ribose) Polymerase-1
- Poly ADP Ribosylation